For the quarter ended June 2026, Groupon (GRPN) reported revenue of $124.68 million, down 0.8% over the same period last year. EPS came in at -$0.04, compared to $0.46 in the year-ago quarter.

The reported revenue represents a surprise of -2.15% over the Zacks Consensus Estimate of $127.42 million. With the consensus EPS estimate being -$0.08, the EPS surprise was +50%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Groupon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Gross Billings: $413.75 million versus the two-analyst average estimate of $422.09 million.
  • Geographic Revenue- North America: $98.21 million versus $99.98 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change.
  • Geographic Revenue- International: $26.46 million versus $27.37 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2.9% change.
  • Geographic Revenue- North America- Local: $92.89 million compared to the $95.55 million average estimate based on two analysts. The reported number represents a change of -1.7% year over year.
  • Geographic Revenue- International- Goods: $1.44 million versus the two-analyst average estimate of $2.16 million. The reported number represents a year-over-year change of -36.5%.
  • Geographic Revenue- North America- Goods: $0.86 million compared to the $0.3 million average estimate based on two analysts. The reported number represents a change of -26.1% year over year.
  • Geographic Revenue- International- Local: $23.98 million compared to the $24.69 million average estimate based on two analysts. The reported number represents a change of +8% year over year.
  • Geographic Revenue- International- Travel: $1.04 million compared to the $0.96 million average estimate based on two analysts. The reported number represents a change of -16.4% year over year.
  • Geographic Revenue- North America- Travel: $4.46 million compared to the $4.13 million average estimate based on two analysts. The reported number represents a change of +2.8% year over year.
  • Revenue- Local: $116.87 million versus the two-analyst average estimate of $119.8 million. The reported number represents a year-over-year change of +0.2%.
  • Revenue- Travel: $5.51 million compared to the $5.08 million average estimate based on two analysts. The reported number represents a change of -1.5% year over year.
  • Revenue- Goods: $2.3 million versus $2.47 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -32.9% change.

View all Key Company Metrics for Groupon here>>>

Shares of Groupon have returned +6.9% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Groupon, Inc. (GRPN): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research